The United States Food and Drug Administration says the shortage of Eli Lilly’s Zepbound and Mounjaro drugs has been resolved ...

Zepbound is the first prescription drug approved specifically to treat the common condition. The Food and Drug Administration ...

The Food and Drug Administration on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment ... pressure machine or never fill their prescription for it. One manufacturer was forced ...

The Food and Drug Administration (FDA) approved a weight-loss drug to help sleep apnea ... Lilly’s Zepbound drug for the use, approving a prescription medicine suited for adults suffering ...

Powerful weight-loss drugs are expanding use of U.S. health care as patients starting prescriptions are diagnosed with ...

The FDA said studies have shown that by aiding weight loss, Zepbound improves sleep apnea symptoms in some patients.

The U.S. Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound.The medicine, part of the class known as GLP-1 ...

However, those who take prescription weight-loss drugs lose, on average, up to 15% of excess body weight, Garvey said, which lowers their risk for related health complications, such as heart disease.